Work

The First FDA-Approved Batches of Botox®

Year: 2022

Type: article

Source: Toxicon

DOI: 10.1016/j.toxicon.2021.11.069

Author: Eric A. Johnson

Institution: University of Wisconsin–Madison

Language: English

Topic: Botulinum Toxin and Related Neurological Disorders

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4288046812

FWCI:

Cites:

Cited by:

Related to: 10